| 000 | 01001 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250513233124.0 | ||
| 264 | 0 | _c20010614 | |
| 008 | 200106s 0 0 eng d | ||
| 022 | _a1015-9770 | ||
| 024 | 7 |
_a10.1159/000049130 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGil-Núñez, A C | |
| 245 | 0 | 0 |
_aAdvantages of lipid-lowering therapy in cerebral ischemia: role of HMG-CoA reductase inhibitors. _h[electronic resource] |
| 260 |
_bCerebrovascular diseases (Basel, Switzerland) _c2001 |
||
| 300 |
_a85-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xtherapeutic use |
| 700 | 1 | _aVillanueva, J A | |
| 773 | 0 |
_tCerebrovascular diseases (Basel, Switzerland) _gvol. 11 Suppl 1 _gp. 85-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000049130 _zAvailable from publisher's website |
| 999 |
_c11181194 _d11181194 |
||